January 26, 2011

Epratuzumab is Safe and Effective for Treatment of Lupus in Phase II Trials

From our latest Research Update Newsletter:
Epratuzumab is an investigational agent for the treatment of lupus. It is an antibody that binds to a protein called CD22 on B cells, which are white blood cells known to be hyperactive in many people with lupus. The researchers hoped to learn whether epratuzumab could be a safe and effective treatment for people with moderate-to-severe lupus. They also wanted to find the best way to give the treatment (which dose and how often to give it) to get the best possible effects.


Want to read these summaries earlier? Sign up for our newsletters here.

1 comment:

Anonymous said...

Epratuzumab is in two Phase III pivotal trials.